A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 14 shares of EXAS stock, worth $742. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Previous 14 -0.0%
Holding current value
$742
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$41.33 - $74.26 $41 - $74
1 Added 7.69%
14 $0
Q1 2024

May 06, 2024

SELL
$56.27 - $73.77 $56 - $73
-1 Reduced 7.14%
13 $0
Q4 2023

May 06, 2024

BUY
$59.06 - $75.72 $59 - $75
1 Added 7.69%
14 $1.04 Million
Q4 2023

Feb 05, 2024

BUY
$59.06 - $75.72 $826 - $1,060
14 New
14 $1.04 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.39B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Di Nuzzo Private Wealth, Inc. Portfolio

Follow Di Nuzzo Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Di Nuzzo Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Di Nuzzo Private Wealth, Inc. with notifications on news.